BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8679519)

  • 1. Vitamin E reduces bleomycin-induced lung fibrosis in mice: biochemical and morphological studies.
    Kilinç C; Ozcan O; Karaöz E; Sunguroğlu K; Kutluay T; Karaca L
    J Basic Clin Physiol Pharmacol; 1993; 4(3):249-69. PubMed ID: 8679519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of bleomycin-induced lung fibrosis by treatment with the platelet activating factor receptor antagonist WEB 2086 in hamsters.
    Giri SN; Sharma AK; Hyde DM; Wild JS
    Exp Lung Res; 1995; 21(2):287-307. PubMed ID: 7539741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposome encapsulation improves the effect of antifibrotic agent in rat lung fibrosis.
    Poiani GJ; Greco M; Choe JK; Fox JD; Riley DJ
    Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1623-7. PubMed ID: 7524983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise Improves Lung Inflammation, but Not Lung Remodeling and Mechanics in a Model of Bleomycin-Induced Lung Fibrosis.
    El-Mafarjeh E; Martins GHC; Probst JJ; Santos-Dias A; Oliveira-Junior MC; de Barros MP; de Oliveira LVF; de Andrade LD; da Palma RK; Moraes-Ferreira R; de Camargo Hizume-Kunzler D; Bachi ALL; Vieira RP
    Oxid Med Cell Longev; 2020; 2020():4302608. PubMed ID: 33123311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ameliorating effect of an interferon inducer polyinosinic-polycytidylic acid on bleomycin-induced lung fibrosis in hamsters. Morphologic and biochemical evidence.
    Giri SN; Hyde DM
    Am J Pathol; 1988 Dec; 133(3):525-36. PubMed ID: 2462354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of suramin on bleomycin-induced lung injury.
    Lossos IS; Izbicki G; Or R; Goldstein RH; Breuer R
    Life Sci; 2000 Oct; 67(23):2873-81. PubMed ID: 11106002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colchicine does not ameliorate bleomycin-induced pulmonary injury in hamsters.
    Ben Yehuda A; Lossos IS; Or R; Ben Chetrit E; Goldstein RH; Conner MW; Breuer R
    Pulm Pharmacol Ther; 1997; 10(1):61-5. PubMed ID: 9344834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human recombinant interferon-alpha2a and interferon-alphaA/D have different effects on bleomycin-induced lung injury.
    Berkman N; Kremer S; Or R; Lossos IS; Christensen TG; Goldstein RH; Breuer R
    Respiration; 2001; 68(2):169-77. PubMed ID: 11287832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of caffeic acid phenethyl ester on bleomycine-induced lung fibrosis in rats.
    Ozyurt H; Söğüt S; Yildirim Z; Kart L; Iraz M; Armutçu F; Temel I; Ozen S; Uzun A; Akyol O
    Clin Chim Acta; 2004 Jan; 339(1-2):65-75. PubMed ID: 14687895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the preventive effect of vitamin C and E on hexavalent chromium induced pulmonary fibrosis in rat.
    Hemmati AA; Nazari Z; Ranjbari N; Torfi A
    Inflammopharmacology; 2008 Aug; 16(4):195-7. PubMed ID: 18759078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive and therapeutic effects of thymosin β4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis.
    Conte E; Fagone E; Gili E; Fruciano M; Iemmolo M; Pistorio MP; Impellizzeri D; Cordaro M; Cuzzocrea S; Vancheri C
    Oncotarget; 2016 Jun; 7(23):33841-54. PubMed ID: 27029074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymosin β4 protects C57BL/6 mice from bleomycin-induced damage in the lung.
    Conte E; Genovese T; Gili E; Esposito E; Iemmolo M; Fruciano M; Fagone E; Pistorio MP; Crimi N; Cuzzocrea S; Vancheri C
    Eur J Clin Invest; 2013 Mar; 43(3):309-15. PubMed ID: 23320620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of bleomycin-induced pulmonary fibrosis by intratracheal administration of antisense oligonucleotides against angiotensinogen mRNA.
    Li X; Zhuang J; Rayford H; Zhang H; Shu R; Uhal BD
    Curr Pharm Des; 2007; 13(12):1257-68. PubMed ID: 17504234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of bleomycin-induced pulmonary fibrosis by a catalytic antioxidant metalloporphyrin.
    Oury TD; Thakker K; Menache M; Chang LY; Crapo JD; Day BJ
    Am J Respir Cell Mol Biol; 2001 Aug; 25(2):164-9. PubMed ID: 11509325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleomycin-induced lung fibrosis in IL-4-overexpressing and knockout mice.
    Izbicki G; Or R; Christensen TG; Segel MJ; Fine A; Goldstein RH; Breuer R
    Am J Physiol Lung Cell Mol Physiol; 2002 Nov; 283(5):L1110-6. PubMed ID: 12376365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amelioration of bleomycin-induced pulmonary injury by cyclosporin A.
    Lossos IS; Or R; Goldstein RH; Conner MW; Breuer R
    Exp Lung Res; 1996; 22(3):337-49. PubMed ID: 8792125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential roles for angiotensin receptor AT1a in bleomycin-induced apoptosis and lung fibrosis in mice.
    Li X; Rayford H; Uhal BD
    Am J Pathol; 2003 Dec; 163(6):2523-30. PubMed ID: 14633624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A upmodulates bleomycin-induced pulmonary fibrosis in BALB/c mice.
    Lossos IS; Or R; Ginzburg V; Christensen TG; Mashriki Y; Breuer R
    Respiration; 2002; 69(4):344-9. PubMed ID: 12169749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymer of proline analogue with sustained antifibrotic activity in lung fibrosis.
    Greco MJ; Kemnitzer JE; Fox JD; Choe JK; Kohn J; Riley DJ; Poiani GJ
    Am J Respir Crit Care Med; 1997 Apr; 155(4):1391-7. PubMed ID: 9105084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abatement of bleomycin-induced pulmonary injury by cell-impermeable inhibitor of phospholipase A2.
    Breuer R; Lossos IS; Or R; Krymsky M; Dagan A; Yedgar S
    Life Sci; 1995; 57(16):PL237-40. PubMed ID: 7564888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.